http://www.mcknights.com/glaxosmithkline/topic/22473/ Articles tagged with GlaxoSmithKline from McKnight's Long Term Care News McKnight's custserv@mcknights.com no The Food and Drug Administration has officially approved Breo Ellipta, a much-anticipated new treatment for chronic obstructive pulmonary disease. http://www.mcknights.com/fda-approves-highly-anticipated-copd-medication/article/292936/ Mon, 13 May 2013 10:30:00 GMT The Food and Drug Administration has officially approved Breo Ellipta, a much-anticipated new treatment for chronic obstructive pulmonary disease. McKnight's The projected recoveries to the federal government from fraud-related audits and investigations are expected to rise 33% — or by $1.7 billion — in fiscal 2012, the Department of Health and Human Services Office of the Inspector General said this week. http://www.mcknights.com/fraud-investigations-audits-bring-dramatically-rising-savings-oig-reports/article/270254/ Thu, 29 Nov 2012 11:30:00 GMT The projected recoveries to the federal government from fraud-related audits and investigations are expected to rise 33% — or by $1.7 billion — in fiscal 2012, the Department of Health and Human Services Office of the Inspector General said this week. McKnight's GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). As a result of the settlement, GSK must change the way it promotes its diabetes drugs, including Avandia. http://www.mcknights.com/gsk-will-pay-90-million-to-settle-diabetes-drug-allegations/article/269291/ Tue, 20 Nov 2012 22:13:46 GMT GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). As a result of the settlement, GSK must change the way it promotes its diabetes drugs, including Avandia. McKnight's GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday. http://www.mcknights.com/gsk-agrees-to-pay-90-million-to-settle-diabetes-drug-allegations/article/268887/ Mon, 19 Nov 2012 11:30:00 GMT GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday. McKnight's